We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Gets Warning Letter for Manufacturing Issues at Calif. Plant
Gilead Gets Warning Letter for Manufacturing Issues at Calif. Plant
October 8, 2010
Gilead has received a warning letter for manufacturing deficiencies at its San Dimas, Calif., facility where three of its drugs are manufactured.